TickerFacts.

Abvc Biopharma, Inc. (ABVC): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-18, first reflected in a filing dated 2019-05-28; 1-for-10, first reflected in a filing dated 2023-08-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

20.11M
Year ended 2025-12-31
+85.2%
3-year compound annual growth
213.88M2016-09-30: 193.98M2017-12-31: 213.32M2018-12-31: 213.88M2020-12-31: 19.72M2021-12-31: 25.05M2022-12-31: 3.17M2023-12-31: 4.34M2024-12-31: 11.67M2025-12-31: 20.11M20.11M
2016-09-30 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3120.11M+72.3%2026-03-03, From 2025-01-01
2024-12-3111.67M+169.3%2026-03-03, From 2024-01-01
2023-12-314.34M+36.9%2025-04-15, From 2023-01-01
2022-12-313.17Mn/c2024-03-13, From 2022-01-01
2021-12-3125.05M+27.1%2023-03-31, From 2021-01-01
2020-12-3119.72Mn/c2022-03-31, From 2020-01-01
No annual figure between 2018-12-31 and 2020-12-31.
2018-12-31213.88M+0.3%2019-04-15, From 2018-01-01
2017-12-31213.32Mn/a2019-04-15, From 2017-01-01
No annual figure between 2016-09-30 and 2017-12-31.
2016-09-30193.98Mn/a2018-01-16, From 2015-10-01